Navigation Links
Mark Rinker Named Vice President of Sales for Blaine Pharmaceuticals

New direction for Blaine Pharmaceuticals

CINCINNATI, Nov. 12 /PRNewswire/ -- Blaine Pharmaceuticals announced today that it has promoted Mark Rinker to Vice President of Sales. Mark will be responsible for all trade relations, market development activities, and sales management as well as evaluating and developing new products to complement the existing Blaine product portfolio.

During his tenure at Blaine Pharmaceuticals, the company has gained significant ground as an over-the-counter (OTC) pharmaceutical company. Blaine's leading product, Mag-Ox 400(R), has expanded distribution in all major food, drug, and mass channels. In 2006, DiaSense(R), a branded line of diabetes supplements was introduced. In 2007, ReliaDose(R) (innovative pediatric medicine delivery system) has been placed in over 27,000 retail locations in the U.S. and internationally.

Mark was hired by Blaine Pharmaceuticals as the Director of International Sales where he helped catapult the company's international presence for Mag-Ox 400(R), DiaSense(R), and ReliaDose(R), in Canada, Japan, South Africa, Central America, Mexico and Korea. Since Mark has been highly involved with the strategic direction of Blaine for the last year, he is armed with knowledge that will be critical in his new position of Vice President of Sales.

Prior to Blaine, Mark served as director of Canadian operations for Omron Healthcare. At Omron, Rinker successfully established Canadian operations. Prior to Omron, Rinker served as a national sales manager with Magna-Pak, Inc., and as a business development manager at Becton Dickinson Canada. Mark graduated from University of Western Ontario with a Bachelor of Administration.

With his new position, Mark will report to Vince Gilday, the Chief Operating Officer. In his new capacity he will work closely with Dreama Kirby, the Chief Marketing Officer to set a strategic direction which focuses on expanding Blaine's market share for its lead products. Now that Blaine has secured significant retail distribution, its objective is to drive the sales of these branded products with considerably more marketing support. These changes within the organization will allow for unprecedented growth of its brands over the next year.

About Blaine Pharmaceuticals

Blaine Pharmaceuticals, founded in 1955, specializes in the development and acquisition of consumer brands with significant value and unrealized potential. Blaine builds sustainable brands by creating consumer demand through recommendations from healthcare professionals. The company's flagship product, Mag-Ox 400(R), is the #1 selling magnesium brand. Other products include the DiaSense(R) family of nutritional supplements and ReliaDose(R), a pediatric medicine-delivery system.

Blaine is committed to cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and business partners to build brands and lay the foundation for future endeavors. For more information, visit .

SOURCE Blaine Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
2. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
3. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
4. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
5. New Director of Nursing Practice Named for Nurses Association
6. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
7. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
8. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
9. Keith Taft Named General Manager of UltraTape Industries
10. AIUM CEO named among most influential in radiology
11. Top Twenty Health Plan Websites Named by
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: